The neuropathological diagnosis of Alzheimer’s disease (AD) requires the presence of two core pathologies: extracellular beta amyloid (amyloid, Aβ) plaques and aggregated tau protein forming intra-neuronal neurofibrillary tangles (tau, NFT) [1,2]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.